Logo image of CANG

CANGO INC/KY-CLASS A (CANG) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CANG - US1375861036 - Common Stock

1.31 USD
+0.03 (+2.34%)
Last: 12/15/2025, 9:37:53 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CANG. CANG was compared to 122 industry peers in the Specialty Retail industry. CANG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CANG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CANG has reported negative net income.
The reported net income has been mixed in the past 5 years: CANG reported negative net income in multiple years.
In the past 5 years CANG reported 4 times negative operating cash flow.
CANG Yearly Net Income VS EBIT VS OCF VS FCFCANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

CANG has a worse Return On Assets (-166.79%) than 95.90% of its industry peers.
CANG has a worse Return On Equity (-324.13%) than 78.69% of its industry peers.
CANG has a Return On Invested Capital of 32.99%. This is amongst the best in the industry. CANG outperforms 97.54% of its industry peers.
Industry RankSector Rank
ROA -166.79%
ROE -324.13%
ROIC 32.99%
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
CANG Yearly ROA, ROE, ROICCANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

In the last couple of years the Profit Margin of CANG has grown nicely.
With an excellent Operating Margin value of 15.51%, CANG belongs to the best of the industry, outperforming 91.80% of the companies in the same industry.
In the last couple of years the Operating Margin of CANG has declined.
CANG has a worse Gross Margin (8.55%) than 91.80% of its industry peers.
In the last couple of years the Gross Margin of CANG has declined.
Industry RankSector Rank
OM 15.51%
PM (TTM) N/A
GM 8.55%
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
CANG Yearly Profit, Operating, Gross MarginsCANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CANG is creating value.
The number of shares outstanding for CANG remains at a similar level compared to 1 year ago.
The number of shares outstanding for CANG has been reduced compared to 5 years ago.
CANG has a worse debt/assets ratio than last year.
CANG Yearly Shares OutstandingCANG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CANG Yearly Total Debt VS Total AssetsCANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 3.88 indicates that CANG is not in any danger for bankruptcy at the moment.
CANG's Altman-Z score of 3.88 is amongst the best of the industry. CANG outperforms 82.79% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that CANG is somewhat dependend on debt financing.
CANG has a Debt to Equity ratio (0.59) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 3.88
ROIC/WACC3.62
WACC9.12%
CANG Yearly LT Debt VS Equity VS FCFCANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

CANG has a Current Ratio of 1.19. This is a normal value and indicates that CANG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CANG (1.19) is worse than 62.30% of its industry peers.
A Quick Ratio of 1.19 indicates that CANG should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.19, CANG belongs to the top of the industry, outperforming 81.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
CANG Yearly Current Assets VS Current LiabilitesCANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2

3. Growth

3.1 Past

The earnings per share for CANG have decreased strongly by -2925.35% in the last year.
The earnings per share for CANG have been decreasing by -13.08% on average. This is quite bad
CANG shows a strong growth in Revenue. In the last year, the Revenue has grown by 1008.65%.
The Revenue for CANG have been decreasing by -11.00% on average. This is quite bad
EPS 1Y (TTM)-2925.35%
EPS 3YN/A
EPS 5Y-13.08%
EPS Q2Q%150%
Revenue 1Y (TTM)1008.65%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%5854.4%

3.2 Future

CANG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.73% yearly.
CANG is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.35% yearly.
EPS Next Y-345.19%
EPS Next 2Y-33.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-17.8%
Revenue Next 2Y-1.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CANG Yearly Revenue VS EstimatesCANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
CANG Yearly EPS VS EstimatesCANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CANG. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 6.88, the valuation of CANG can be described as very cheap.
Based on the Price/Forward Earnings ratio, CANG is valued cheaper than 96.72% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CANG to the average of the S&P500 Index (23.79), we can say CANG is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.88
CANG Price Earnings VS Forward Price EarningsCANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

CANG's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CANG is cheaper than 95.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.43
CANG Per share dataCANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

A cheap valuation may be justified as CANG's earnings are expected to decrease with -33.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.73%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CANG!.
Industry RankSector Rank
Dividend Yield 0%

CANGO INC/KY-CLASS A

NYSE:CANG (12/15/2025, 9:37:53 AM)

1.31

+0.03 (+2.34%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-01 2025-12-01/amc
Earnings (Next)03-04 2026-03-04
Inst Owners6.06%
Inst Owner Change23.43%
Ins Owners0.49%
Ins Owner ChangeN/A
Market Cap135.96M
Revenue(TTM)2.95B
Net Income(TTM)-2.23B
Analysts82.86
Price Target4.08 (211.45%)
Short Float %N/A
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1499.62%
Min EPS beat(2)-3070.37%
Max EPS beat(2)71.13%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.27%
Min Revenue beat(2)2.11%
Max Revenue beat(2)12.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-50%
PT rev (3m)-50%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-96.13%
EPS NY rev (1m)50%
EPS NY rev (3m)-65.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.88
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.39
EV/EBITDA 2.43
EPS(TTM)-10.52
EYN/A
EPS(NY)0.19
Fwd EY14.54%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.03
BVpS0.94
TBVpS0.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -166.79%
ROE -324.13%
ROCE 41.76%
ROIC 32.99%
ROICexc 32.99%
ROICexgc 33%
OM 15.51%
PM (TTM) N/A
GM 8.55%
FCFM N/A
ROA(3y)-3.88%
ROA(5y)3.21%
ROE(3y)-6.46%
ROE(5y)4.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-6.32%
ROICexgc growth 5Y-14.8%
ROICexc growth 3Y-5.17%
ROICexc growth 5Y-14.28%
OM growth 3Y61.58%
OM growth 5Y-5.43%
PM growth 3YN/A
PM growth 5Y6.57%
GM growth 3Y-7.64%
GM growth 5Y-20.99%
F-ScoreN/A
Asset Turnover2.21
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 0.73
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 3.88
F-ScoreN/A
WACC9.12%
ROIC/WACC3.62
Cap/Depr(3y)348.58%
Cap/Depr(5y)264.99%
Cap/Sales(3y)38.63%
Cap/Sales(5y)23.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2925.35%
EPS 3YN/A
EPS 5Y-13.08%
EPS Q2Q%150%
EPS Next Y-345.19%
EPS Next 2Y-33.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1008.65%
Revenue growth 3Y-41.04%
Revenue growth 5Y-11%
Sales Q2Q%5854.4%
Revenue Next Year-17.8%
Revenue Next 2Y-1.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1110.46%
EBIT growth 3Y-4.73%
EBIT growth 5Y-15.84%
EBIT Next Year199.54%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-220.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-130.21%
OCF growth 3YN/A
OCF growth 5YN/A

CANGO INC/KY-CLASS A / CANG FAQ

What is the fundamental rating for CANG stock?

ChartMill assigns a fundamental rating of 3 / 10 to CANG.


What is the valuation status of CANGO INC/KY-CLASS A (CANG) stock?

ChartMill assigns a valuation rating of 3 / 10 to CANGO INC/KY-CLASS A (CANG). This can be considered as Overvalued.


How profitable is CANGO INC/KY-CLASS A (CANG) stock?

CANGO INC/KY-CLASS A (CANG) has a profitability rating of 2 / 10.